Administered By

• Duke Clinical Research Institute

Awarded By

• Basilea Pharmaceutica 

Contributors

• Fowler Jr., Vance Garrison Principal Investigator
• Holland, Thomas Lawrence Co Investigator

Start/End

• November 1, 2018 - August 31, 2022